Related Experiment Video
Updated: Aug 22, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Hypertensive Conditions: Hypertensive Disorders in Pregnancy
Cecilia M Kipnis1, Patrick L Daly2, Emily T Goodwin1
1Naval Hospital Jacksonville Family Medicine Residency, 2080 Child St, Jacksonville, FL 32214.
Insights
Hypertensive disorders in pregnancy (HDP) require vigilant monitoring and management throughout gestation and postpartum. Early intervention with low-dose aspirin and appropriate antihypertensives can mitigate risks associated with these serious conditions.
Area of Science:
- Obstetrics and Gynecology
- Cardiovascular Medicine
- Maternal-Fetal Medicine
Background:
- Hypertensive disorders in pregnancy (HDP) encompass a range of conditions impacting maternal health during and after pregnancy.
- These disorders are linked to increased maternal morbidity, mortality, and long-term cardiovascular disease risk.
- The spectrum includes gestational hypertension, preeclampsia, eclampsia, HELLP syndrome, and chronic hypertension.
Purpose of the Study:
- To summarize the clinical presentation, management, and monitoring of hypertensive disorders in pregnancy.
- To highlight the importance of early detection and intervention strategies for high-risk pregnancies.
- To outline current therapeutic recommendations for blood pressure management in HDP.
Main Methods:
- Review of current literature and clinical guidelines regarding hypertensive disorders in pregnancy.
- Analysis of diagnostic criteria and risk stratification for preeclampsia.
- Evaluation of pharmacological interventions for blood pressure control and prevention.
Main Results:
- Low-dose aspirin is recommended for preeclampsia prevention in high-risk women after 12 weeks' gestation.
- Close monitoring of blood pressure, laboratory values, and fetal well-being is crucial.
- Specific antihypertensives like labetalol and nifedipine are first-line treatments for outpatient and inpatient management.
Conclusions:
- Hypertensive disorders in pregnancy necessitate comprehensive management strategies.
- Postpartum vigilance is essential as HDP can develop or worsen after delivery.
- Effective management reduces immediate and long-term health risks for affected women.
Abstract:
Hypertensive disorders in pregnancy (HDP) represent a spectrum of disease that affect women through pregnancy and the immediate postpartum period. These conditions are associated with significant morbidity and mortality during and after pregnancy and have been linked to cardiovascular disease later in life. The HDP spectrum includes gestational hypertension (HTN), preeclampsia, eclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome, chronic HTN, and chronic HTN with superimposed preeclampsia. Low-dose aspirin is recommended as a preventive drug after 12 weeks' gestation in women who are at high risk of preeclampsia. In HDP, close blood pressure (BP) monitoring, laboratory evaluation, and fetal assessment are warranted. Labetalol and nifedipine extended release are first-line oral antihypertensives for outpatient BP management of chronic HTN; labetalol, hydralazine, and nifedipine immediate release are used for hospitalized patients. HDP may develop or progress in the postpartum period; continued vigilance is important in the puerperium.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart...

